Arch Biopartners Submits Application to the Turkish Ministry of Health to Conduct a Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide
TORONTO, Sept. 22, 2023 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX…
Safety Training Seminars Opens New CPR Certification Training School in Carmel and Monterey, CA
Niqo Robotics Unveils North America’s Widest Hooded AI Weeder Expanding Its RoboWeeder Lineup for Specialty Crops
CEO.CA’s Inside the Boardroom: “Best Positioned” in 20 Years: Starcore is Scaling in Mexico
Elauwit Connection Earns Honorable Mention for Multifamily Partner of the Year at 2026 Broadband Communities Awards
TempraMed Announces LIFE Offering up to C$8 Million to Accelerate Global Expansion and Fulfilment of Forecasted Demand